Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Raise $500M Through Senior Notes Offering

NEW YORK – Agilent Technologies said on Monday that it has priced an underwritten, registered public offering of a series of its senior notes, in an aggregate principal amount of $500 million.

In a filing with the US Securities and Exchange Commission, the company said that the notes will mature in June 2030 and will bear interest at an annual rate of 2.1 percent. The offering is expected to close on June 4, and Agilent is expecting net proceeds of about $494.3 million.

The company plans to use the funds from the offering for general corporate purposes, including, together with cash on hand, to repay borrowings under its term loan facility.

Bank of America Securities, Mizuho Securities USA, and Wells Fargo Securities are acting as joint book-running managers.

Agilent's shares were up a fraction of 1 percent to $90.15 in mid-morning trading on the New York Stock Exchange. 

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.